4 Nov 2013 | Medication Safety
The International Medication Safety Network (IMSN) recognises unsafe medicine naming, labelling and packaging as an ongoing global threat to patient safety which requires a collaborative approach. Medication errors affect millions of patients globally, sometimes leading to death or serious harm. Frequent causes of preventable errors include:
In many countries, medicine regulation fails to recognise the importance of safe design and human factors in the selection and design of medicine names, labels and packaging.
The IMSN has released a position statement on making medicine naming, labelling and packaging safer, and recommends the following as part of a comprehensive, worldwide solution:
At the Safer Naming, Labeling and Packaging of Medicine Conference in October 2013 Dr Michael Cohen, chairperson of the IMSN, proposed that regulators and other stakeholders join IMSN at a summit in 2014 to address this global threat to patient safety.
About IMSN: The IMSN is an international network involving medication safety organisations, and medication safety experts and advocates. Established in November 2006 by the ‘Salamanca Declaration to Promote Safe Medication Practices Globally’, IMSN aims to prevent patient harm globally by promoting safe medication practices and collaboration between everyone involved in the medication use process. For more information visit their website: www.intmedsafe.net.